PT Enseval Putera Megatrading Tbk. (EPMT.JK)
IDR 2360.0
(0.0%)
IDR 2360.0
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -683.1 Billion IDR | 30.58% |
| 2022 | -984.02 Billion IDR | 24.97% |
| 2021 | -1311.55 Billion IDR | 17.68% |
| 2020 | -1593.18 Billion IDR | -59.78% |
| 2019 | -997.08 Billion IDR | 21.03% |
| 2018 | -1262.64 Billion IDR | -55.6% |
| 2017 | -811.49 Billion IDR | 30.97% |
| 2016 | -1175.52 Billion IDR | -19.37% |
| 2015 | -984.8 Billion IDR | -63.22% |
| 2014 | -603.35 Billion IDR | -111.91% |
| 2013 | -284.72 Billion IDR | 61.41% |
| 2012 | -737.89 Billion IDR | -0.83% |
| 2011 | -731.82 Billion IDR | -231.6% |
| 2010 | -220.69 Billion IDR | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q3 | -224.72 Billion IDR | -507.61% |
| 2024 Q1 | -305.25 Billion IDR | 55.31% |
| 2024 Q2 | 54.69 Billion IDR | 117.92% |
| 2023 Q2 | 41.12 Billion IDR | 107.9% |
| 2023 Q1 | -520.42 Billion IDR | 47.11% |
| 2023 Q4 | -683.1 Billion IDR | -77.73% |
| 2023 FY | -683.1 Billion IDR | 30.58% |
| 2023 Q3 | -384.35 Billion IDR | -1034.5% |
| 2022 Q3 | -535.59 Billion IDR | 27.69% |
| 2022 Q4 | -984.02 Billion IDR | -83.73% |
| 2022 FY | -984.02 Billion IDR | 24.97% |
| 2022 Q1 | -1080.49 Billion IDR | 17.62% |
| 2022 Q2 | -740.7 Billion IDR | 31.45% |
| 2021 Q2 | -712.6 Billion IDR | 47.53% |
| 2021 Q1 | -1358.16 Billion IDR | 14.75% |
| 2021 Q4 | -1311.55 Billion IDR | -12.84% |
| 2021 FY | -1311.55 Billion IDR | 17.68% |
| 2021 Q3 | -1162.32 Billion IDR | -63.11% |
| 2020 Q1 | -983.7 Billion IDR | 1.34% |
| 2020 Q3 | -1340.55 Billion IDR | -192.36% |
| 2020 Q4 | -1593.18 Billion IDR | -18.85% |
| 2020 FY | -1593.18 Billion IDR | -59.78% |
| 2020 Q2 | -458.52 Billion IDR | 53.39% |
| 2019 Q3 | -692.6 Billion IDR | -108.08% |
| 2019 FY | -997.08 Billion IDR | 21.03% |
| 2019 Q4 | -997.08 Billion IDR | -43.96% |
| 2019 Q2 | -332.85 Billion IDR | 73.78% |
| 2019 Q1 | -1269.27 Billion IDR | -0.52% |
| 2018 Q1 | -866.35 Billion IDR | -6.76% |
| 2018 Q2 | -546.24 Billion IDR | 36.95% |
| 2018 Q3 | -1071.9 Billion IDR | -96.23% |
| 2018 FY | -1262.64 Billion IDR | -55.6% |
| 2018 Q4 | -1262.64 Billion IDR | -17.8% |
| 2017 Q3 | -675.71 Billion IDR | -11.43% |
| 2017 Q1 | -755.34 Billion IDR | 35.74% |
| 2017 Q2 | -606.38 Billion IDR | 19.72% |
| 2017 Q4 | -811.49 Billion IDR | -20.09% |
| 2017 FY | -811.49 Billion IDR | 30.97% |
| 2016 FY | -1175.52 Billion IDR | -19.37% |
| 2016 Q2 | -670.15 Billion IDR | 23.21% |
| 2016 Q3 | -1053.14 Billion IDR | -57.15% |
| 2016 Q4 | -1175.52 Billion IDR | -11.62% |
| 2016 Q1 | -872.68 Billion IDR | 11.39% |
| 2015 Q3 | -507.59 Billion IDR | -70.97% |
| 2015 Q2 | -296.89 Billion IDR | 48.84% |
| 2015 Q1 | -580.34 Billion IDR | 3.81% |
| 2015 FY | -984.8 Billion IDR | -63.22% |
| 2015 Q4 | -984.8 Billion IDR | -94.02% |
| 2014 Q2 | -18.47 Billion IDR | 95.37% |
| 2014 Q4 | -603.35 Billion IDR | -64.25% |
| 2014 FY | -603.35 Billion IDR | -111.91% |
| 2014 Q3 | -367.33 Billion IDR | -1888.66% |
| 2014 Q1 | -399.09 Billion IDR | -40.17% |
| 2013 FY | -284.72 Billion IDR | 61.41% |
| 2013 Q2 | -191.84 Billion IDR | 65.93% |
| 2013 Q1 | -563.13 Billion IDR | 23.68% |
| 2013 Q3 | -189.23 Billion IDR | 1.36% |
| 2013 Q4 | -284.72 Billion IDR | -50.46% |
| 2012 Q3 | -377.05 Billion IDR | 0.0% |
| 2012 Q4 | -737.89 Billion IDR | -95.7% |
| 2012 FY | -737.89 Billion IDR | -0.83% |
| 2011 FY | -731.82 Billion IDR | -231.6% |
| 2010 FY | -220.69 Billion IDR | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| PT Itama Ranoraya Tbk | 148.83 Billion IDR | 558.979% |
| PT Kimia Farma (Persero) Tbk | 7094.31 Billion IDR | 109.629% |
| PT Millennium Pharmacon International Tbk | 651.43 Billion IDR | 204.862% |
| PT Soho Global Health Tbk | -668.51 Billion IDR | -2.182% |